Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 468

1.

The structure and biological features of fibrinogen and fibrin.

Mosesson MW, Siebenlist KR, Meh DA.

Ann N Y Acad Sci. 2001;936:11-30. Review.

PMID:
11460466
2.
3.

Fibrinogen and fibrin structure and functions.

Mosesson MW.

J Thromb Haemost. 2005 Aug;3(8):1894-904. Review.

4.

Fibrinogen assembly and crosslinking on a fibrin fragment E template.

Mosesson MW, Siebenlist KR, Hernandez I, Wall JS, Hainfeld JF.

Thromb Haemost. 2002 Apr;87(4):651-8.

PMID:
12008948
5.

The covalent structure of factor XIIIa crosslinked fibrinogen fibrils.

Mosesson MW, Siebenlist KR, Hainfeld JF, Wall JS.

J Struct Biol. 1995 Jul-Aug;115(1):88-101.

PMID:
7577232
6.

Fibrinogen structure and fibrin clot assembly.

Mosesson MW.

Semin Thromb Hemost. 1998;24(2):169-74. Review.

PMID:
9579639
7.

Structure and function of human fibrinogen inferred from dysfibrinogens.

Matsuda M, Sugo T.

Int J Hematol. 2002 Aug;76 Suppl 1:352-60. Review.

PMID:
12430881
8.

The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin.

Siebenlist KR, DiOrio JP, Budzynski AZ, Mosesson MW.

J Biol Chem. 1990 Oct 25;265(30):18650-5.

9.

Evidence for four different polymerization sites involved in human fibrin formation.

Olexa SA, Budzynski AZ.

Proc Natl Acad Sci U S A. 1980 Mar;77(3):1374-8.

11.

Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.

Siebenlist KR, Meh DA, Mosesson MW.

Thromb Haemost. 2001 Nov;86(5):1221-8.

PMID:
11816711
12.
13.

Evaluation of the factors contributing to fibrin-dependent plasminogen activation.

Mosesson MW, Siebenlist KR, Voskuilen M, Nieuwenhuizen W.

Thromb Haemost. 1998 Apr;79(4):796-801.

PMID:
9569195
14.

Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin.

Pospisil CH, Stafford AR, Fredenburgh JC, Weitz JI.

J Biol Chem. 2003 Jun 13;278(24):21584-91. Epub 2003 Apr 7.

15.

Crystal structure of a 30 kDa C-terminal fragment from the gamma chain of human fibrinogen.

Yee VC, Pratt KP, Côté HC, Trong IL, Chung DW, Davie EW, Stenkamp RE, Teller DC.

Structure. 1997 Jan 15;5(1):125-38.

PMID:
9016719
17.

Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis.

Siebenlist KR, Mosesson MW.

J Biol Chem. 1994 Nov 11;269(45):28414-9.

18.

Hereditary disorders of fibrinogen.

Matsuda M, Sugo T.

Ann N Y Acad Sci. 2001;936:65-88. Review.

PMID:
11460526
19.

Fibrinogen naples I (B beta A68T) nonsubstrate thrombin-binding capacities.

Meh DA, Mosesson MW, Siebenlist KR, Simpson-Haidaris PJ, Brennan SO, DiOrio JP, Thompson K, Di Minno G.

Thromb Res. 2001 Jul 1;103(1):63-73.

PMID:
11434947
20.

Nonclottable fibrin obtained from partially reduced fibrinogen: characterization and tissue plasminogen activator stimulation.

Procyk R, Medved L, Engelke KJ, Kudryk B, Blombäck B.

Biochemistry. 1992 Mar 3;31(8):2273-8.

PMID:
1540582

Supplemental Content

Support Center